NLE Renal & Urinary Nursing — Renal & Urinary Assessment & DiagnosticsStudy Notes

The kidney is a complex organ that performs far more than simple waste excretion. Each of the two kidneys contains approximately one million nephrons—the functional filtering units—arranged to maximize surface area for filtration and selective reabsorption. The nephron consists of the glomerulus (where filtration begins), the proximal convoluted tubule (where glucose, amino acids, and ions are reabsorbed), the loop of Henle (which creates the osmotic gradient for water reabsorption), the distal convoluted tubule, and the collecting duct (where final adjustments to urine concentration occur). Blood enters the glomerulus via the afferent arteriole under pressure; water, electrolytes, glucose, amino acids, and urea filter into Bowman's capsule, while blood proteins and cells remain in the blood. As filtrate moves through the tubules, essential substances are reabsorbed back into the peritubular capillaries, and additional secretion of ions and waste occurs, yielding the final urine product. The kidney performs five essential physiological functions that directly impact your nursing assessment and patient care: **Excretion of Metabolic Waste:** The kidney excretes urea (the primary end product of protein metabolism) and creatinine (derived from muscle creatine phosphate metabolism at a steady, predictable rate). When kidney function declines, these wastes accumulate, causing uremia—a toxic condition affecting multiple organ systems. This is why rising BUN and creatinine are the clinical hallmarks of renal dysfunction. **Fluid and Electrolyte Balance:** The kidney regulates blood volume and osmolality by controlling water reabsorption (via antidiuretic hormone/ADH in the collecting duct) and electrolyte handling. Sodium is the key electrolyte for volume regulation; aldosterone increases sodium and water reabsorption when blood volume drops. Potassium excretion is vital—the kidney excretes ~90% of dietary potassium, so renal failure rapidly causes hyperkalemia, the most lethal complication of kidney disease. **Acid-Base Balance:** The kidney excretes hydrogen ions (H+) via the proximal tubule and collecting duct and reabsorbs bicarbonate (HCO3−), thus fine-tuning blood pH. Renal disease causes metabolic acidosis because the kidneys lose their ability to excrete excess acid. **Blood Pressure Control:** Via the renin-angiotensin-aldosterone system (RAAS), the kidney senses decreased perfusion (as in dehydration or heart failure) and releases renin from juxtaglomerular cells. Renin converts angiotensinogen to angiotensin I; angiotensin-converting enzyme (ACE) in the lungs produces angiotensin II, which is a potent vasoconstrictor and stimulates aldosterone release. Aldosterone increases sodium and water reabsorption, raising blood volume and blood pressure. This system explains why ACE inhibitors and ARBs are so effective in both hypertension and renal disease—they block angiotensin II formation, reducing vasoconstriction and intraglomerular pressure. **Endocrine Functions:** The kidney produces erythropoietin (EPO), which stimulates red blood cell production in the bone marrow; renal failure causes anemia. The kidney also hydroxylates vitamin D to its active form (calcitriol), essential for calcium absorption from the intestine. Kidney failure causes secondary hyperparathyroidism and renal bone disease because of vitamin D deficiency and phosphate retention. **Normal Urine Production & Clinical Significance:** Normal urine output is approximately **1–2 mL/kg/hr** in adults, or about **1,500 mL/day** on average. For rapid clinical assessment, a minimum adequate output is approximately **30 mL/hr** (or **0.5 mL/kg/hr**) in adults, which signals adequate renal perfusion. As a nurse, you must recognize these abnormal patterns: - **Oliguria:** <400 mL/day (or <0.5 mL/kg/hr)—a red flag for acute kidney injury (AKI) or severe chronic kidney disease (CKD). Oliguria means the kidneys are failing to excrete adequate waste and fluid. - **Anuria:** <100 mL/day—complete or near-complete renal failure; requires urgent intervention. - **Polyuria:** >2,500 mL/day—excessive urine output seen in diabetes insipidus, hyperglycemia (osmotic diuresis), or early renal disease with loss of concentrating ability. - **Nocturia:** frequent nighttime urination; in CKD, the kidney loses the ability to concentrate urine, so patients void at night to eliminate fluid. Daily monitoring of urine output is a core nursing responsibility. Sustained oliguria (especially after the first 24 hours of illness) is an ominous sign requiring immediate notification of the physician.

A thorough renal and urinary assessment requires both subjective (history) and objective (physical examination and vital signs) data. This assessment forms the baseline against which all laboratory and diagnostic findings are interpreted and nursing diagnoses are formulated. **Health History: The Renal Story** When taking a renal history, explore **changes in voiding patterns and appearance**, which are often the first signs of renal or urinary disease: - **Frequency:** normally 4–8 voids per day in adults. Increased frequency (pollakiuria) may indicate UTI, diabetes, or early renal disease. Decreased frequency may signal retention or oliguria. - **Urgency and dysuria:** urgency (strong desire to void immediately) and dysuria (painful urination, often burning) are classic UTI signs; also consider urethritis, cystitis, or pyelonephritis. - **Hesitancy:** difficulty initiating the stream; suggests outlet obstruction or neurogenic bladder. - **Retention and incontinence:** inability to void (retention) despite full bladder; uncontrolled loss (incontinence) due to weak sphincter, neurological disease, or overflow. - **Nocturia:** more than 2 nighttime voids; in healthy young adults usually reflects evening fluid intake, but in CKD/diabetes insipidus it signals loss of concentrating ability. - **Urine appearance:** ask about color (normal pale yellow to amber), odor (normal faint, but foul smells suggest infection), presence of blood (hematuria—stones, infection, cancer), cloudiness (WBCs, bacteria, crystals), or froth (proteinuria). **Fluid Intake & Output Patterns:** - How much water/fluids does the patient drink daily? In CKD, fluid intake often needs restriction. - Any changes in thirst? Excessive thirst (polydipsia) suggests hyperglycemia or diabetes insipidus. - Estimate 24-hour output: does it match intake? Negative balance (output > intake) suggests dehydration or diuretic use; positive balance suggests fluid retention. **Weight Changes & Edema:** - Rapid weight gain (e.g., 2–3 kg in 1–2 days) with edema signals fluid retention from renal disease or heart failure. - Rapid weight loss may indicate dehydration, malnutrition, or wasting from uremia. **Pain & Symptom History:** - **Flank pain** (side/back): suggests pyelonephritis (usually sudden onset, fever, chills) or renal stones (severe, colicky pain radiating to groin). - **Suprapubic pain** (lower abdomen): cystitis (bladder infection). - **Uremic symptoms:** if chronic kidney disease is suspected, ask about nausea, vomiting, fatigue, shortness of breath, muscle cramps, or itching—all indicate uremia. **Medication & Nephrotoxin History:** This is critical. Ask about: - **Aminoglycoside antibiotics** (gentamicin, tobramycin): dose-dependent nephrotoxicity; monitor renal function closely and use extended-interval dosing when possible. - **NSAIDs** (ibuprofen, naproxen): inhibit prostaglandins needed for renal perfusion; dangerous in dehydration, CKD, or heart failure. - **ACE inhibitors/ARBs:** can reduce GFR acutely if patient is dehydrated or has bilateral renal artery stenosis; monitor creatinine after initiation. - **Contrast dye (iodinated):** causes contrast-induced nephropathy (CIN), especially in diabetics or those with baseline renal impairment; requires hydration and renal monitoring. - **Cisplatin** (chemotherapy): highly nephrotoxic; requires aggressive hydration. - **Herbal/alternative remedies:** some (e.g., certain Chinese herbs) are nephrotoxic; in the Philippine context, ask about traditional herbal use. **Past Medical History:** - Diabetes mellitus (leading cause of CKD and ESRD). - Hypertension (both cause and consequence of kidney disease). - Recurrent UTIs, pyelonephritis, or renal calculi (stone history predisposes to future stones and obstruction). - Autoimmune diseases (SLE, vasculitis), glomerulonephritis. - Prostate disease (men) or gynecological issues (women) affecting bladder emptying. **Physical Examination: Objective Renal Assessment** **Vital Signs & Weight:** - **Blood pressure:** elevated in renal disease (fluid retention, RAAS activation); hypotension suggests dehydration or acute renal hypoperfusion. - **Temperature:** fever + flank pain + dysuria = pyelonephritis (requires urgent antibiotic therapy). - **Daily weight (gold-standard fluid assessment):** weigh at the same time each morning, same scale, same clothing. **A 1 kg weight gain ≈ 1 L (1,000 mL) fluid retention**. Gains of 2–3 kg in 24–48 hours signal fluid overload; progressive daily gains suggest fluid retention from renal disease. Weight loss may indicate dehydration or catabolism from uremia. **General Appearance:** - **Pallor:** anemia from renal EPO deficiency (normal in CKD). - **Skin dryness and poor turgor:** dehydration or uremia (urea in sweat causes itching and dryness). - **Uremic frost:** white crystalline deposits on skin from urea precipitation; rare but indicates severe, end-stage renal disease. **Edema Assessment:** - **Periorbital edema** (puffy eyes, especially morning): often the first visible sign of nephrotic syndrome (massive proteinuria). - **Sacral edema** (bedbound patients) or **dependent edema** (feet/ankles in ambulatory patients): assess using 1+ (slight pitting) to 4+ (severe) scale. Generalized edema with weight gain suggests nephrotic syndrome or acute glomerulonephritis. - Edema + low serum albumin + hypertension + hematuria = likely glomerulonephritis. **Lungs:** - **Crackles (rales)** on auscultation: fine, bibasilar crackles indicate fluid overload/pulmonary edema from renal failure. This is an emergency sign requiring diuretics and possibly dialysis. - **Orthopnea** (shortness of breath lying flat): also suggests pulmonary edema. **Cardiovascular:** - **Jugular venous distension (JVD):** sign of fluid overload; measure JVD with patient supine at 45 degrees; >4 cm above sternal angle suggests volume overload. - **Hypertension:** very common in renal disease; a contributing factor to progression. **Abdomen & Flank:** - **Palpation for distended bladder:** a full bladder is palpable/percussable as a dull mass above the symphysis pubis; suggests retention. - **Costovertebral angle (CVA) tenderness:** percuss the flanks (areas over kidneys at the 12th rib level). Tenderness suggests pyelonephritis, renal infarction, or abscess. Perform gently; CVA tenderness + fever + dysuria = pyelonephritis. - **Abdominal/flank pain:** ask the patient to localize pain. Colicky (sudden, severe, wavelike) pain radiating from flank to groin = renal colic (kidney stone). **Genitourinary Exam:** - Observe for urethral discharge (suggests urethritis), genital rashes, or signs of trauma. - In women, rule out vaginal infection (can mimic UTI symptoms). - In men, assess for prostate tenderness (DRE if trained); enlarged prostate → urinary retention. **Neurological Considerations (if CKD is advanced):** - Asterixis (flapping tremor): sign of uremia affecting the brain. - Confusion or altered mental status: uremic encephalopathy. - Peripheral neuropathy: uremic neuropathy (distal, bilateral, lower extremities first).

The renal function panel—consisting of BUN, creatinine, GFR, and electrolytes—is the cornerstone of renal assessment and interpretation. These values must be memorized as normal values are the reference against which all disorders are judged. The NLE tests these relentlessly because they guide every clinical decision in renal nursing. **Blood Urea Nitrogen (BUN): Normal = 10–20 mg/dL** BUN is the concentration of urea (the major end product of protein metabolism) in the blood. It is filtered by the kidneys but is also partially reabsorbed in the proximal tubule, especially when urine flow is slow (low urine output) or fluid intake is low. This makes BUN **non-specific**—it rises not only in renal disease but also in conditions that increase urea production or decrease urine flow. **Why BUN is misleading:** - **Dehydration/hypovolemia:** fluid loss concentrates BUN; urine flow decreases, allowing more urea reabsorption → BUN rises even with normal kidney function. - **High-protein diet or catabolism:** increased protein breakdown produces more urea → higher BUN. - **Gastrointestinal bleeding:** blood in the GI tract is a protein source; urea production rises → higher BUN. - **Liver disease:** the liver synthesizes most urea; liver failure → lower BUN (opposite of kidney disease). - **Drugs:** certain medications (diuretics, corticosteroids) increase protein breakdown → higher BUN. For these reasons, **BUN alone is not a reliable indicator of kidney function**. Nurses often see patients with BUN of 25–30 mg/dL who actually have normal kidneys but are dehydrated. Always compare BUN to creatinine using the ratio. **Serum Creatinine: Normal = 0.6–1.2 mg/dL** (slightly lower in women and older adults due to less muscle mass) Creatinine is produced at a **steady, predictable rate from muscle creatine phosphate metabolism**. It is freely filtered by the glomerulus and is NOT reabsorbed by the tubules. Thus, creatinine concentration reflects kidney function: as GFR falls, creatinine rises. **Serum creatinine is the single most specific and reliable indicator of renal function** because it is unaffected by diet, hydration status, or other factors—only by the kidneys' ability to filter it. **Important caveats:** - Creatinine may be low in elderly, frail, or malnourished patients (low muscle mass) despite reduced GFR; never assume normal creatinine = normal kidneys in older adults. - Creatinine rises more slowly than GFR declines; a patient can have 50% loss of kidney function with a "normal" creatinine of 1.2 if baseline was 0.6. - Acute changes in creatinine (rising rapidly over days) suggest acute kidney injury; gradual rises suggest chronic kidney disease. **The BUN-to-Creatinine Ratio: Interpreting the Pattern** The normal ratio is approximately **10:1 to 20:1** (BUN ÷ creatinine). This ratio is a diagnostic tool to distinguish the **cause** of elevated BUN/creatinine: **High BUN:Creatinine Ratio (>20:1) with Normal Creatinine = PRERENAL Azotemia (Problem is BEFORE the kidney)** Example: BUN 30, Cr 1.0 → ratio 30:1 (>20:1). This pattern means: - Dehydration or hypovolemia (most common). - Low renal perfusion (as in heart failure, sepsis, or hemorrhage). - The kidneys themselves are functioning, but they are not being perfused adequately. - Intervention: restore fluids or perfusion; creatinine should normalize within 24–48 hours if fluid status corrected. This is **reversible** if caught early. **Normal or Low BUN:Creatinine Ratio (10–20:1) with Rising Creatinine = INTRINSIC Renal Disease (Problem IS in the kidney)** Example: BUN 22, Cr 2.5 → ratio 8.8:1 (normal). This pattern means: - The kidney tubules are damaged and cannot reabsorb urea normally (fractional excretion of urea increases). - Acute glomerulonephritis, acute tubular necrosis (ATN), sepsis with direct renal injury, drug-induced nephrotoxicity, or chronic kidney disease. - Intervention: investigate the cause; the elevation is less reversible than prerenal disease. **Both BUN and Creatinine Rising Proportionally with a Ratio of 20:1 = POSTRENAL Azotemia (Problem is AFTER the kidney – obstruction)** Example: BUN 60, Cr 3.0 → ratio 20:1. This pattern suggests: - Obstruction of urine flow (kidney stones, tumor, enlarged prostate, blocked catheter). - Urine backs up; urea is reabsorbed; creatinine continues to rise (cannot be reabsorbed). - Intervention: relieve the obstruction urgently to prevent permanent renal damage. If obstruction lasts >2 weeks, interstitial fibrosis develops and kidney function may not fully recover. **Clinical Pearls on BUN and Creatinine:** - In **acute illness**, serial creatinine (checking every 6–12 hours) is more informative than a single value; rising creatinine in acute settings signals AKI and requires urgent intervention. - In **chronic kidney disease**, creatinine may be stable, but it is still elevated above baseline and represents permanent kidney function loss. - Always ask, "What is this patient's baseline creatinine?" A Cr of 1.5 may be normal for a muscular male but represents significant kidney disease in a frail elderly woman. **Serum Electrolytes in Renal Disease** The kidney is responsible for excreting excess electrolytes and retaining what the body needs. Renal disease disrupts this balance, causing characteristic patterns: **Potassium (Normal = 3.5–5.0 mEq/L)** Hyperkalemia (K+ >5.0, especially >6.0) is the **most dangerous complication of kidney failure** because high potassium depolarizes the heart's conduction system, causing fatal arrhythmias. In renal failure, the kidney cannot excrete dietary potassium (~90% of excretion normally occurs here); potassium accumulates rapidly. **Sources of potassium in renal failure:** - Dietary intake (bananas, oranges, potatoes, tomatoes, avocados, nuts). - Medications (ACE inhibitors, ARBs, NSAIDs, potassium-sparing diuretics). - Tissue breakdown (hemolysis, rhabdomyolysis, tumor lysis). - **Oral potassium supplements** should be stopped in renal failure. **Hypokalemia (K+ <3.5)** is less common in kidney disease but occurs with excessive diuretic use before kidney function is severely impaired, or in early renal disease with significant urinary losses. Hypokalemia causes muscle weakness, cardiac arrhythmias, and metabolic alkalosis. **Sodium (Normal = 135–145 mEq/L)** In renal failure, the kidneys cannot excrete excess sodium; sodium and water are retained together, causing hypertension and edema. Dietary sodium restriction is a key intervention in CKD and dialysis. Hyponatremia (Na+ <135) is less common but can occur if the patient drinks excessive free water while the kidneys cannot excrete it (SIADH-like picture). **Calcium (Normal = 8.5–10.5 mg/dL)** In kidney disease, serum calcium is typically **LOW (hypocalcemia)** due to: - **Loss of active vitamin D production:** without 1,25-dihydroxyvitamin D, intestinal calcium absorption decreases. - **Phosphate retention:** in renal failure, phosphate accumulates; high phosphate binds calcium, lowering ionized calcium and triggering secondary hyperparathyroidism. Hypocalcemia causes muscle cramps, tetany, and cardiac arrhythmias; chronic hypocalcemia causes secondary hyperparathyroidism (PTH rises to try to mobilize calcium from bone), leading to renal bone disease (mixed osteitis fibrosa and ostemalacia). **Phosphate (Normal = 2.5–4.5 mg/dL)** In advanced renal disease (GFR <30), phosphate retention causes **hyperphosphatemia**. High phosphate: - Precipitates calcium (worsens hypocalcemia). - Causes secondary hyperparathyroidism. - Damages heart, blood vessels, and bone (vascular and soft-tissue calcification). Intervention: **phosphate-binding agents** (calcium-based or non-calcium binders) taken with meals bind dietary phosphate in the GI tract, preventing absorption. Dietary phosphate restriction (limit meat, dairy, processed foods) is also essential. **Bicarbonate/Acid-Base Status in Renal Disease** The kidney excretes hydrogen ions and reabsorbs bicarbonate. In renal failure, both functions decline, causing **metabolic acidosis** (pH <7.35, HCO3− <22 mEq/L). Chronic metabolic acidosis: - Increases protein catabolism and muscle wasting. - Worsens renal bone disease. - Decreases hemoglobin oxygen affinity (worsens tissue oxygenation). - Causes respiratory compensation (Kussmaul breathing). Intervention: sodium bicarbonate supplementation may be warranted if HCO3− falls below 18–20 mEq/L; however, sodium intake must be monitored in volume-overloaded patients.

While serum creatinine tells you that the kidneys are filtering, **GFR tells you HOW WELL they are filtering**. GFR is defined as the volume of plasma filtered by the kidneys per minute, expressed as mL/min/1.73 m² (normalized to body surface area for comparison across individuals). **GFR is the single best overall measure of kidney function** because it directly reflects the kidneys' ability to clear waste. Understanding GFR and its interpretation is essential for the NLE and for clinical practice. **Normal GFR Values and Interpretation** **Normal GFR ≈ 90–120 mL/min/1.73 m²** in healthy adults. Notably, young adults and athletes may have GFR up to 130–140 mL/min. As people age, GFR normally declines by ~1 mL/min/1.73 m² per year after age 30; this is a normal aging process, not necessarily renal disease. **Estimated GFR (eGFR) and Calculating It** In practice, **GFR is estimated (eGFR)** from serum creatinine, age, sex, race, and body size using the **CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equation** or older MDRD equation. The most common formula used in the Philippines and internationally is: **eGFR = 141 × (Scr/Λ)^α × 0.993^Age × (0.988 if female)** Where Scr = serum creatinine, Λ = 0.7 (for women) or 1.0 (for men), and α = −0.329 (for women) or −0.411 (for men). However, for the NLE, you do **not need to memorize this formula**—modern labs auto-calculate eGFR from creatinine. Your role is to **interpret the result** and understand its clinical implications. **Key point for nurses:** Always request eGFR calculation when ordering or receiving creatinine results. A patient with Cr = 1.5 and eGFR = 45 has significantly reduced function, whereas one with Cr = 1.5 and eGFR = 75 may have near-normal function (the difference is age and muscle mass). **Stages of Chronic Kidney Disease (CKD) Based on GFR** The kidney disease community classifies CKD into five stages based on GFR, independent of cause: - **Stage 1: GFR ≥90 mL/min/1.73 m²** — Normal or high; kidney function is normal, but kidney damage may be present (albuminuria, imaging abnormality). Example: diabetes with early proteinuria, GFR still >90. - Nursing focus: prevention; tight glycemic/BP control; lifestyle modification. - **Stage 2: GFR 60–89 mL/min/1.73 m²** — Mildly decreased kidney function; kidney damage evident. Example: hypertensive on medication, trace proteinuria, GFR 75. - Nursing focus: slow progression; ACE inhibitor/ARB to reduce proteinuria; BP target <130/80; education. - **Stage 3a: GFR 45–59 mL/min/1.73 m²** — Moderately decreased kidney function; ~40–50% loss of kidney function. Example: diabetic with baseline Cr 1.0 now 1.3, eGFR 52. - Nursing focus: increased monitoring; medication adjustment for renal function (renally dose drugs); phosphate/potassium begin to rise; refer to nephrology if not already. - **Stage 3b: GFR 30–44 mL/min/1.73 m²** — Moderately decreased kidney function; ~55–70% loss. Example: CKD from lupus, Cr 2.0, eGFR 35. - Nursing focus: close specialist follow-up; anemia screening; bone disease monitoring; phosphate binders; prepare patient for dialysis in 1–2 years if progression. - **Stage 4: GFR 15–29 mL/min/1.73 m²** — Severely decreased kidney function; ~70–85% loss. Example: late diabetic nephropathy, Cr 3.5, eGFR 18. - Nursing focus: urgent nephrology; prepare for renal replacement therapy (dialysis/transplant); monthly or more frequent clinic visits; education on ESRD; vascular access planning. - **Stage 5: GFR <15 mL/min/1.73 m² (ESRD/Kidney Failure)** — Kidney failure; nearly complete loss of function; dialysis or transplant required to sustain life. - Nursing focus: dialysis initiation; management of complications (hypertension, anemia, bone disease, cardiovascular); transplant evaluation; psychosocial support. **Clinical Significance of GFR Thresholds** Each stage has practical clinical triggers: - At **GFR 30–40:** phosphate retention begins; phosphate binders and vitamin D supplementation often started; hematocrit monitoring for anemia. - At **GFR 20–30:** nephrology referral should be established; renal replacement therapy counseling; preparation for access (AVF/graft for HD, peritoneal dialysis catheter placement). - At **GFR <15:** renal replacement therapy must begin; without dialysis/transplant, uremia is fatal within weeks. **GFR in Acute Kidney Injury (AKI)** AKI is characterized by a **rapid decline in GFR over hours to days** (often a drop of 50% or more from baseline). The KDIGO (Kidney Disease: Improving Global Outcomes) classification defines AKI in stages: - **Stage 1:** 1.5–1.9× baseline creatinine (or GFR decrease 25–49%) with oliguria <6 hrs/day. - **Stage 2:** 2.0–2.9× baseline creatinine (or GFR decrease 50–74%) with oliguria 6–12 hrs/day. - **Stage 3:** ≥3× baseline creatinine (or GFR decrease ≥75%, or baseline GFR <35) with oliguria >12 hrs/day or anuria. Rapid creatinine rise is an emergency sign requiring urgent intervention to prevent progression to ESRD. **GFR and Medication Dosing (Renally Dosed Drugs)** One of the most critical nursing responsibilities is recognizing that **many drugs are renally excreted and accumulate in kidney disease**. Standard drug doses are based on normal renal function (GFR ≥60). In CKD, doses must be adjusted to prevent toxicity. Common renal-dosed drugs include: - **Antibiotics:** aminoglycosides (gentamicin, tobramycin), fluoroquinolones (ciprofloxacin), cephalosporins, penicillins (especially in severe renal failure). - **Antivirals:** acyclovir, ganciclovir, lamivudine. - **Anticonvulsants:** phenytoin, phenobarbital, gabapentin. - **Analgesics:** NSAIDs (use cautiously or avoid), morphine (metabolite accumulation → confusion). - **Cardiovascular:** digoxin (major toxicity risk), captopril/enalapril (monitor for hyperkalemia), beta-blockers (labetalol, atenolol). **Nursing role:** Before administering any drug in a patient with CKD or AKI, check the eGFR/creatinine clearance and verify the dose is appropriate. Question doses that seem high for the GFR. Consult pharmacy when unsure. This prevents adverse drug events. **GFR and Contrast Dye (Contrast-Induced Nephropathy)** In patients with baseline eGFR <30 (or creatinine >1.5), iodinated radiographic contrast dye poses significant risk for **contrast-induced nephropathy (CIN)**—acute renal injury from direct tubular toxicity and renal vasoconstriction. Risk is highest in diabetics and those with severe CKD. Prevention of CIN: - If possible, use non-contrast imaging (ultrasound, MRI without gadolinium). - If contrast necessary: pre-hydrate with normal saline IV; use **low-osmolality contrast** (LOCM) or **iso-osmolality contrast** (IOCM) rather than high-osmolality; minimize contrast volume (total dose ≤5 mL/kg body weight). - **Hold metformin** 48 hours before and after contrast (risk of lactic acidosis if renal function acutely declines). - Check creatinine 48–72 hours post-contrast; a rise >25% or absolute rise >0.5 mg/dL = CIN. - Encourage post-contrast hydration to flush the dye.

Urinalysis (UA) is the **single most useful and cost-effective** renal diagnostic test. A routine UA takes minutes, costs <$5, and provides a wealth of clinical information. The NLE repeatedly tests UA interpretation because it is so fundamental to bedside diagnosis. Every nurse must be fluent in reading a urinalysis report. **Components of Routine Urinalysis** **1. Color** - **Normal:** pale yellow to amber (varies with hydration—concentrated urine is darker, dilute urine is pale). - **Abnormal colors and their meanings:** - **Red/pink/cola color:** hematuria (RBCs in urine from stones, infection, glomerulonephritis, tumors) or myoglobin (rhabdomyolysis). Dipstick will be positive for blood. - **Brown/tea color:** myoglobin or hemoglobin, or bilirubin (liver disease). If dipstick negative for blood but urine is brown, suspect myoglobin. - **Cloudy/turbid:** infection (WBCs, bacteria), crystals, or lipiduria (nephrotic syndrome). - **Milky white:** lipiduria (nephrotic syndrome, chyluria from lymphatic disease). - **Black/very dark:** alkaptonuria (rare metabolic disorder) or melanuria (melanoma). **2. Clarity** - **Clear:** normal. - **Cloudy/turbid:** suggests infection, crystals, or casts; always correlate with microscopy (see below). **3. Odor** - **Normal:** faint, non-specific. - **Foul/ammonia-like:** UTI (bacteria produce ammonia). - **Fruity/acetone-like:** diabetic ketoacidosis (ketones in urine). - **Musty:** rare; phenylketonuria (PKU, a genetic metabolic disorder). **4. Specific Gravity** - **Normal range: 1.005–1.030** (varies with hydration). - **High (>1.030):** concentrated urine, indicating dehydration, fever, or low fluid intake. - **Low (<1.010, especially if fixed at ~1.010):** dilute urine, indicating excessive fluid intake, but in kidney disease, a **fixed specific gravity ~1.010 = ISOSTHENURIA** (lost ability to concentrate urine), signaling **renal failure**. This is a critical sign; the kidney has lost its concentrating power. - **Very high (>1.050):** suggests significant solute load (glucose in diabetic ketoacidosis, or contrast dye if just administered—always ask if contrast was used). **Clinical Pearl:** Specific gravity is the single best screening test for renal concentrating ability; a fixed low SG in a patient with oliguria or elevated creatinine is diagnostic of established renal failure. **5. pH** - **Normal: 4.5–8.0** (average ~6, slightly acidic). - **High pH (>8):** alkaline urine; may suggest UTI with urease-producing organisms (Proteus), or can result from medications (acetazolamide) or dietary factors. Alkaline urine favors precipitation of certain crystals (phosphate, magnesium ammonium phosphate/struvite) and stone formation. - **Low pH (<4.5):** acidic urine; seen in acidosis, high protein diet, fever, or certain medications. Acidic urine favors uric acid and calcium oxalate stone formation. **6. Protein (Proteinuria)** - **Normal:** negative or trace (<10 mg/dL). - **1+ (30 mg/dL), 2+ (100 mg/dL), 3+ (300 mg/dL), 4+ (>1000 mg/dL):** pathological proteinuria. **Clinical significance:** - **Small amounts (trace to 1+):** can be normal with fever, intense exercise, dehydration, or orthostatic proteinuria (occurs only when upright); repeat on first morning specimen. - **Persistent moderate to heavy proteinuria:** indicates glomerular disease. Example: nephrotic syndrome (proteinuria >3.5 g/day, low serum albumin, edema). - **Proteinuria in diabetes or hypertension:** early sign of diabetic nephropathy or hypertensive kidney disease; initiation of ACE inhibitor/ARB significantly slows progression. - **Microalbuminuria (30–300 mg/day, detected on urine microalbumin test):** earliest sign of diabetic kidney disease; screening in all diabetics annually. **7. Glucose (Glucosuria)** - **Normal:** negative (urine glucose appears only when serum glucose exceeds the **renal threshold**, normally ~180 mg/dL, at which point the tubules are saturated and cannot reabsorb all the filtered glucose). - **Positive:** glucosuria indicates either: - **Hyperglycemia (serum glucose >180–200):** as in uncontrolled diabetes. - **Low renal threshold:** rare; genetic condition where glucose spills into urine at lower serum levels (benign, no treatment). - **Acute kidney injury:** damaged tubules cannot reabsorb glucose even at normal serum levels. **Note:** Dipsticktests for glucose detect only glucose, not other reducing sugars; fructose and galactose (from rare metabolic disorders) would be missed on dipstick but detected by special reducing substance tests (Clinitest). **8. Ketones** - **Normal:** negative. - **Positive:** indicates ketonuria (ketone bodies in urine), seen in: - **Diabetic ketoacidosis (DKA):** urgent medical emergency; patient is metabolically very acidotic. - **Starvation or fasting:** during prolonged fasting, the body burns fat for energy, producing ketones. - **Low-carbohydrate diet:** body metabolizes fat → ketones. **Note:** The dipstick detects acetoacetate and acetone but NOT beta-hydroxybutyrate (the predominant ketone in DKA); serum beta-hydroxybutyrate is more specific for DKA diagnosis. **9. Blood (Hemoglobin) and RBCs** - **Normal:** negative (no blood/hemoglobin in urine). - **Positive dipstick for blood but NO RBCs on microscopy:** indicates myoglobin (from rhabdomyolysis, crush injury, severe exertion, or muscle disease). Myoglobin is smaller than RBCs and passes through the dipstick filter. - **Hematuria (RBCs in urine):** **dysmorphic RBCs** (distorted RBCs) or **RBC casts** suggest glomerulonephritis; **isomorphic (normal) RBCs** suggest non-glomerular causes (stones, tumors, infection). Always investigate hematuria; while benign causes are common, hematuria can signal serious disease (renal cancer, bladder cancer). **Significant hematuria is defined as:** - **Gross hematuria:** visible blood in urine (patient reports pink/red/tea-colored urine); any gross hematuria requires investigation. - **Microscopic hematuria:** >3 RBCs per high-power field (hpf) on microscopy; if persistent and not explained by infection/menstruation, refer for urology workup. **10. Nitrites** - **Normal:** negative. - **Positive:** suggests bacteriuria (bacteria reduce dietary nitrates to nitrites); indicates UTI. However, some bacteria (Pseudomonas, Staphylococcus saprophyticus initially) do not produce nitrites; a negative nitrite does not rule out UTI. **11. Leukocyte Esterase** - **Normal:** negative. - **Positive:** suggests WBCs in urine (pyuria) indicating urinary tract inflammation from infection (UTI, pyelonephritis), interstitial cystitis, or other inflammatory conditions. **12. White Blood Cells (WBCs)** - **Normal:** 0–5 WBCs per hpf on microscopy. - **>5 WBCs/hpf:** pyuria; usually from infection but can occur in non-infectious inflammation (interstitial cystitis, renal infarction). - **WBC casts:** (see Casts below) indicate pyelonephritis or interstitial nephritis. **Microscopy: Casts (The Most Specific Finding)** Casts are cylindrical structures formed in the distal tubule and collecting duct from Tamm-Horsfall protein (uromodulin) and trapped cells/crystals. The type of cast indicates the location and nature of kidney disease. **Hyaline casts:** composed of just Tamm-Horsfall protein; 0–2 per low-power field (lpf) is normal; increased numbers suggest dehydration, fever, intense exercise, or diuretic use. Not pathological by themselves. **RBC casts:** RBCs trapped in the cast matrix; **ALWAYS pathological**—indicates active glomerulonephritis (kidney inflammation affecting the glomerulus). Example: post-streptococcal GN, IgA nephropathy, lupus nephritis. **WBC casts:** WBCs in the cast; indicates **acute pyelonephritis, interstitial nephritis, or glomerulonephritis**. Associated with pyuria and bacteria. Example: bacterial pyelonephritis = fever + CVA tenderness + proteinuria/hematuria + WBC casts + WBCs in urine. **Granular casts:** contain cellular debris/granules; may be fine (non-specific, seen in acute illness) or coarse (more concerning, seen in chronic kidney disease). **Waxy/broad casts:** indicate chronic renal disease, nephrotic-range proteinuria, or end-stage renal disease; formed in dilated tubules due to slow flow and tubular atrophy. **Crystals** Crystals in urine may be normal (calcium oxalate, uric acid) or pathological (cystine, drug crystals). - **Calcium oxalate crystals:** most common; can form stones in acidic urine; seen with high dietary oxalate (nuts, spinach, chocolate), dehydration, or kidney stones. - **Uric acid crystals:** yellow-brown, needle-like; seen in acidic urine or gout; stone formation risk. - **Struvite (magnesium ammonium phosphate) crystals:** coffin-lid or prism shape; form in alkaline urine; associated with Proteus or Klebsiella UTI; stones composed of struvite are radiopaque and can become large (staghorn calculi). - **Cystine crystals:** hexagonal; pathological, seen only in cystinosis (rare genetic disorder); cystine stones form in acidic urine and are radiolucent. - **Drug crystals (sulfonamides, ampicillin, acyclovir):** needle-like; can cause acute tubular obstruction, especially with dehydration; ensure adequate hydration with these drugs. **Bacteria and Squamous Epithelial Cells** - **Bacteria:** may indicate contamination (common in improperly collected specimens) or actual UTI. A **clean-catch midstream specimen** minimizes contamination; if >100,000 colony-forming units (CFU/mL) of a single organism is cultured (plus symptoms), it confirms UTI. - **Squamous epithelial cells:** indicate contamination, especially from the distal urethra/perineum. A properly collected UA should have <5 squamous cells; >10 suggests poor collection and the specimen should be recollected. **How to Collect a Proper Urinalysis Specimen** Specimen quality greatly affects interpretation. For **routine urinalysis, a first-morning specimen** is preferred because it is most concentrated (highest specific gravity, highest protein/RBC/WBC detection) and free from orthostatic effects. For **urinary tract infection diagnosis, a clean-catch midstream specimen** is standard: 1. **First void of the morning:** use the **first-morning specimen** for routine UA, not the first void after fluid intake. 2. **Clean-catch, midstream (for UTI diagnosis):** (1) provide the patient with sterile wipes and sterile container; (2) instruct females to spread labia, wipe front-to-back with each wipe, discard first void, collect midstream urine in sterile cup; (3) males: retract foreskin (if uncircumcised), wipe glans with sterile wipe, discard first void, collect midstream; (4) cap the specimen immediately. 3. **Container:** sterile, labeled with patient name, date, time. 4. **Timing:** analyze within 2 hours of collection (delays allow bacterial overgrowth, RBC lysis, crystal formation that may not reflect in-vivo urine composition). If delay is unavoidable, refrigerate the specimen (cold slows bacterial growth). 5. **For 24-hour protein collection:** discard the first morning void, then collect ALL urine for the next 24 hours into a large (2–3 L) container (may contain preservative); keep cool/refrigerated. Patient must not lose any urine. **Interpreting a Complete Urinalysis: The Clinical Picture** **Example 1: UTI (Cystitis)** UA findings: cloudy urine, WBCs 20–50/hpf, bacteria (rods or cocci), nitrites positive, leukocyte esterase positive, maybe some RBCs (irritation). Symptoms: dysuria, frequency, urgency. Nursing action: Urine culture before antibiotics; empirical antibiotic often started pending culture (nitrofurantoin, cephalexin, or fluoroquinolone depending on local resistance patterns); encourage fluids; follow-up UA post-treatment. **Example 2: Acute Glomerulonephritis** UA findings: proteinuria (1+ to 3+), hematuria (cola-colored urine), RBC casts (VERY significant), WBCs, hypertension on BP. No bacteria, no nitrites. Nursing assessment: acute glomerular disease (post-streptococcal GN, IgA nephritis, lupus, vasculitis). Differential: no UTI (no nitrites, no bacteria). Labs: low complement (C3), anti-streptococcal antibodies (if PSGN), or ANA/anti-dsDNA (if lupus). Nursing action: Bed rest, fluid/sodium restriction, monitor BP, urinalysis q1–2 weeks, serial creatinine to assess kidney function. **Example 3: Nephrotic Syndrome** UA findings: heavy proteinuria (3+ to 4+, often >3 g/day on 24-hour collection), lipiduria (waxy granules, oval fat bodies under polarizing microscope), maybe RBCs but NO RBC casts, specific gravity high due to protein. Labs: serum albumin <2.5 g/dL, hyperlipidemia, edema, hypertension. Differential: nephrotic syndrome (not nephritic; RBC casts absent). Causes: minimal change disease (most common in children), focal segmental glomerulosclerosis (FSGS), membranoproliferative GN, membranous nephropathy (adults). Nursing action: protein restriction (but not so low as to worsen hypoalbuminemia), sodium restriction, diuretics if edema, prophylactic anticoagulation (thrombosis risk), immunosuppression depending on cause. **Example 4: Rhabdomyolysis (Crush Injury)** UA findings: positive dipstick for blood but NO RBCs on microscopy (myoglobin is not a cellular element). Urine cola-colored. Creatinine rises acutely. CK (creatine kinase) in serum is very high (often >1,000 U/L). Nursing action: URGENT aggressive IV hydration (can prevent acute kidney injury from myoglobin precipitation in tubules); monitor urine output (goal ≥200 mL/hr); alkalinize urine with sodium bicarbonate IV (myoglobin is less likely to precipitate in alkaline urine); monitor potassium (rhabdo releases K+ from muscles → hyperkalemia); monitor for compartment syndrome if crush injury. **Example 5: Diabetic Nephropathy (Early)** UA findings: microalbumin (30–300 mg/day on urine microalbumin test; not visible on dipstick but detectable by specialized testing), no hematuria, no WBCs, normal pH and specific gravity, no casts. Serum: glucose control parameter (A1C), creatinine still normal or only mildly elevated, hypertension. Nursing action: ACE inhibitor or ARB (renal protection); tight glucose control (A1C <7%); blood pressure target <130/80; counsel on kidney-protective lifestyle; annual screening for progression. **Example 6: Renal Failure (ESRD)** UA findings: may be unremarkable (no proteinuria, no hematuria, no casts) OR may show heavy proteinuria + casts (depends on cause). Specific gravity fixed at 1.010 (isosthenuria). Serum: creatinine >4–5 mg/dL, BUN >100 mg/dL, K+ >5.5, HCO3− <18, eGFR <15. UA interpretation: the absence of findings does NOT rule out renal failure; some causes (like diabetic nephropathy in end-stage, or interstitial fibrosis) may have a benign-looking UA despite complete kidney failure. The diagnosis is made by lab values, not UA alone.

Beyond laboratory and urinalysis findings, imaging and invasive diagnostic procedures provide detailed visual information about kidney structure, size, position, and pathology. Each procedure has specific indications, preparation requirements, and post-procedure nursing care. **Kidney-Ureter-Bladder (KUB) X-ray** **Indication:** screening for radiopaque stones (calcium oxalate, uric acid, struvite), positioning of kidneys, gross anatomical abnormalities. **Advantages:** simple, rapid, no contrast, no radiation risk (low-dose), inexpensive. **Limitations:** cannot visualize soft tissues or function; cannot detect radiolucent stones (cystine, drug-induced). **Nursing considerations:** no special prep; patient positioned supine; can be done portably if patient unstable. Interpret with clinical context (KUB + hematuria + flank pain = likely stone). **Renal Ultrasound** **Indication:** evaluate kidney size, shape, presence of obstruction (hydronephrosis), masses (tumors, cysts), renal perfusion (Doppler), rule out AAA (abdominal aortic aneurysm) expansion. **Advantages:** NO radiation, NO contrast, painless, widely available, inexpensive, can be done portably at bedside, repeatable without risk. **Limitations:** operator-dependent (requires skilled ultrasonographer); cannot assess renal function; difficult in obese patients or those with bowel gas; cannot visualize small stones. **Nursing prep:** patient may be asked to drink water 30 minutes before (full bladder improves visualization) or fast (depending on protocol). No other prep. Gel applied to skin (warm), transducer glided across abdomen and flank. Takes ~20–30 minutes. **Post-procedure:** gel wiped off; patient can resume normal activity immediately. **Clinical use example:** A patient with AKI and suspected obstruction (high BUN/creatinine, oliguria) should have renal ultrasound as first-line imaging to detect hydronephrosis (fluid backup in collecting system = obstruction). If hydronephrosis present → urology consult for relief (stent, percutaneous nephrostomy). **Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI)** **CT Abdomen/Pelvis with Contrast (CT Urography)** **Indication:** definitive diagnosis of kidney stones (detects all types, radiopaque and radiolucent), renal tumors, obstructions, renal/ureteral calcifications, vascular abnormalities (renal artery stenosis). **Advantages:** fast, detailed cross-sectional images, detects small stones, good tissue differentiation. **Disadvantages:** **radiation exposure**; **iodinated contrast dye** (risk of contrast-induced nephropathy in CKD); expensive. **Nursing considerations:** - **Before CT with IV contrast:** (1) assess for **iodine/shellfish allergy** (cross-reactivity with iodinated contrast; if allergy confirmed, use **non-ionic low-osmolality contrast** or premedicate with corticosteroids + antihistamine); (2) check **serum creatinine/eGFR** to assess risk of CIN (if GFR <30, CIN risk very high; if GFR 30–60, moderate risk; if GFR >60, low risk); (3) ensure patient is **well-hydrated**; (4) **HOLD metformin** 48 hours before and after (lactic acidosis risk if renal function acutely declines with contrast); (5) have IV access placed. - **During CT:** patient lies on table; contrast injected IV; scanner takes images. Ensure patient remains still. Tell patient to report any chest pain, shortness of breath, or severe allergic reaction (severe reactions rare but possible). - **After CT:** (1) **remove IV line after protocol time** (usually 4–24 hours post-contrast); (2) **encourage oral hydration** to dilute contrast and promote renal clearance (push fluids for 12–24 hours); (3) restart **metformin 48 hours post-contrast** only if post-contrast creatinine has not risen >0.5 mg/dL or >25%; (4) monitor for **CIN signs** (acute rise in creatinine 48–72 hours post-contrast); (5) educate patient that mild nausea/flushing during contrast injection is normal. **MRI** **Indication:** renal masses (differentiates cysts from tumors), renal artery stenosis, renal infarction, complex anatomy (especially in transplant patients). **Advantages:** **NO radiation, NO iodinated contrast** (important in contrast allergy or severe renal failure); excellent soft-tissue detail; can assess tissue perfusion and function (functional MRI). **Disadvantages:** slower than CT; contraindicated with certain metallic implants (pacemakers, cochlear implants, metallic foreign bodies in eyes); more expensive than CT; patient must remain still in narrow space (claustrophobia risk). **Nursing considerations:** - Screen for **metallic implants** before MRI (absolutely contraindicated: cardiac pacemakers, ferromagnetic aneurysm clips; relative contraindications: some stents, metal fragments in eyes). Ask if patient has had metallic objects in eyes (from industrial work) and check X-ray. - Some MRI units use **gadolinium contrast** (safer than iodinated contrast, no CIN risk); however, in patients with **severe renal failure (eGFR <15)**, gadolinium carries rare risk of **nephrogenic systemic fibrosis (NSF)** (irreversible fibrosis of skin/internal organs). If MRI with gadolinium absolutely necessary in severe CKD, use **linear chelated gadolinium agents** (safer) and ensure post-MRI hydration. - Patient positioned in MRI machine; loud banging/knocking noises occur (normal); earplugs provided. Procedure takes 30–60 minutes. - **Post-MRI:** hydrate if gadolinium used; resume normal activity. **Intravenous Pyelogram (IVP) / Intravenous Urography (IVU)** **Indication:** visualize entire urinary tract (kidneys, ureters, bladder) to detect obstruction, stones, or abnormalities of collecting system. Less commonly used now (replaced by ultrasound and CT) but still tested on NLE. **Procedure:** iodinated IV contrast injected; X-ray films taken at intervals as contrast flows through the kidneys and down the ureters into the bladder, outlining the urinary system. **Advantages:** functional information (can assess how quickly each kidney excretes); less radiation than CT; lower contrast dose than CT. **Disadvantages:** **iodinated contrast** (CIN risk); requires complete bladder emptying at the end; delayed films may take 1–2 hours; cannot detect non-opacifying stones or assess tissue in detail. **Nursing prep (critical):** 1. **NPO 8 hours before** (empty stomach; bowel prep often ordered—enema or laxative evening before and morning of—to clear bowel gas that obscures images). 2. **Bowel preparation:** patient may be ordered to drink GoLYTELY or have fleet enema evening before; some facilities use bisacodyl tablets or suppository morning of exam. 3. **Allergy screening:** **ask about iodine/shellfish allergy**; if allergic, notify radiologist immediately—may require premedication or alternative imaging. 4. **Baseline renal function:** check creatinine/eGFR before procedure. 5. **IV access:** patent line for contrast injection. 6. **Timing:** NPO status must be maintained until after procedure. **During IVP:** - Patient positioned supine on X-ray table. - Preliminary (scout) film taken. - IV contrast injected (tell patient to expect warm/flushed sensation; brief; normal). - Serial X-rays taken at specific intervals (usually 1, 3, 5, 10, and 15 minutes) as contrast moves through system. - Tell patient to lie still and take slow, deep breaths; warn that films may require compression band on abdomen (uncomfortable but necessary to visualize ureters). - **Post-contrast film:** patient voids, then film taken to assess bladder emptying (should empty completely). **After IVP (Critical Nursing Care):** 1. **Remove IV line** after protocol time (usually 4–24 hours post-contrast). 2. **Aggressive hydration:** **push oral fluids** (water, clear fluids) to dilute contrast and flush kidneys—give patient clear instructions: "Drink water frequently for the next 24 hours." Aim for 200+ mL/hr for 12–24 hours post-procedure. 3. **Resume diet:** patient may eat after procedure (not fasting); clear liquids initially if tolerated, then advance to regular diet. 4. **Monitor urine output:** urine may be slightly discolored from contrast; this is normal. Output should be ≥30 mL/hr; if oliguria, increase fluid intake and notify physician (may indicate CIN developing). 5. **Monitor for CIN:** check creatinine 48–72 hours post-IVP; a rise >0.5 mg/dL or >25% above baseline = CIN. Notify physician if CIN suspected. 6. **Medications:** restart **metformin 48 hours post-contrast** only if post-contrast creatinine is stable (not risen >25%). 7. **Allergy monitoring:** though delayed reactions are rare, educate patient to report rashes, itching, or difficulty breathing in days following procedure. **Cystoscopy** **Indication:** direct visualization of the bladder and urethra to diagnose bladder tumors, hematuria source (biopsy if needed), interstitial cystitis, urethral strictures, stones, or foreign bodies. Also therapeutic (stone removal, stent placement, dilation of strictures). **Procedure:** rigid or flexible cystoscope (telescope-like instrument with light and camera) inserted through the urethra into the bladder under sterile conditions. Saline irrigation used to distend bladder for visualization. Takes 10–30 minutes depending on findings. **Anesthesia:** local anesthesia (lidocaine gel in urethra) for flexible cystoscopy; general anesthesia often used for rigid cystoscopy or if extensive procedures planned. **Nursing Prep:** 1. **NPO 6–8 hours before** (anesthesia requirement). 2. **Enema or laxative evening before** (to clear bowel for better visualization). 3. **Informed consent:** explain procedure, risks (bleeding, infection, urinary retention, perforation—rare), and what to expect (discomfort, urge to void during procedure). 4. **IV access:** establish for sedation/medications. 5. **Vital signs baseline:** record BP, HR, temperature. 6. **Empty bladder:** patient voids before transport to OR/procedure room. **During Cystoscopy:** - Patient positioned supine (or lithotomy for gynecological approach). - Sterile field maintained; drapes applied. - Anesthesia/sedation administered (usually IV). - Cystoscope inserted; procedure performed (biopsy, fulguration, stone removal, stent placement). - Keep patient NPO until anesthesia fully worn off; monitor vital signs continuously. **Immediate Post-Procedure (First 24 Hours) - Critical Nursing Care:** 1. **Expect pink/reddish urine and mild burning:** normal from instrumentation; reassure patient. 2. **Void within 2–4 hours:** if unable to void, check for acute retention (distended bladder palpable/percussable above symphysis). If retention: assess for pain, amount of sedation still present, spinal anesthesia effects. Catheterize only if unable to void after 6 hours or patient in severe pain; document reason. 3. **Monitor urine output:** pink-tinged urine is normal, but watch for: - **Bright-red bleeding/clots:** may indicate bleeding from biopsy site; increase fluids, monitor closely; notify physician if persistent (may need cystoscopy for fulguration). - **Inability to void:** retention; see above. 4. **Dysuria (urinary burning):** common; analgesics (acetaminophen, NSAIDs) usually effective; warm sitz bath helps (15–20 minutes, q2–3h). 5. **Monitor for infection signs:** fever >38.5°C, chills, severe dysuria, cloudy/foul-smelling urine → UTI; obtain urinalysis and culture; start antibiotics if fever/systemic signs. 6. **Avoid strenuous activity/heavy lifting:** rest for 24 hours; resume normal activity next day if no complications. 7. **Follow-up:** if biopsy taken, results available in 5–7 days; if stone/tumor removed, imaging may be repeated in 2–4 weeks. **Late Post-Procedure (>24 Hours):** - Persistent hematuria beyond 48 hours: investigate (imaging if hematuria continues; may signal underlying pathology or complication). - Persistent fever/dysuria: likely UTI; culture confirms; antibiotics adjust based on sensitivities. - Inability to void: may need catheterization if obstruction/stricture developed. - Gross blood clots: rare; notify physician immediately (may require return to OR). **Renal Biopsy** **Indication:** definitive diagnosis of glomerulonephritis (to guide immunosuppressive therapy), nephrotic syndrome of unknown cause, declining renal function of uncertain etiology, lupus nephritis (to assess activity and severity), vasculitis, or other glomerular diseases. **Procedure:** guided by ultrasound or CT, a needle (usually Tru-Cut or spring-loaded biopsy needle) is inserted through the skin (just below rib 12) percutaneously into the kidney to obtain a small core of renal tissue. The kidney is highly vascular; only a few millimeters of tissue are needed. Takes 10–15 minutes. Done under local anesthesia + light IV sedation. **Contraindications (relative/absolute):** - Uncontrolled hypertension (risk of bleeding). - Bleeding disorder/anticoagulation (INR >1.5, platelets <50,000). - Single kidney or ESRD (risk of losing remaining function). - Urinary tract infection (can seed bacteria into kidney). - Uncooperative patient (cannot stay still). **Nursing Prep:** 1. **Blood work:** CBC (baseline Hgb, platelets), coagulation profile (PT/INR, PTT); send to blood bank for type and crossmatch (in case transfusion needed). 2. **NPO 6–8 hours.** 3. **Informed consent:** explain risks: bleeding (major risk, occurring in 4–7% of biopsies, usually minor and self-limited but can require transfusion or rarely nephrectomy), infection, hematuria, pain. 4. **Baseline vital signs, weight, Hgb/Hct.** 5. **IV access:** establish. 6. **Baseline urine pregnancy test** if female of childbearing age. 7. **Empty bladder:** patient voids before procedure. **During Biopsy:** - Patient prone on procedure table, pillow under abdomen (to elevate kidney). - Skin prepped, draped in sterile field. - Local anesthesia (lidocaine) infiltrated; sedation given IV. - Ultrasound transducer applied to guide needle insertion; needle advanced to kidney, tissue obtained (usually 1–3 passes). - Patient may feel pressure or brief discomfort; tell patient to hold breath when needle passed (to keep kidney still). - Dressing applied; transport to recovery. **Immediate Post-Procedure (First 24 Hours) - CRITICAL Nursing Care:** The kidney is highly vascular; hemorrhage is the major complication. **Strict bed rest** is mandatory. 1. **Bed rest for minimum 6–24 hours** (depending on bleeding risk and institutional protocol); patient should NOT ambulate or sit in chair initially. Monitor closely during first 2 hours. 2. **Vital signs every 15 minutes × 4 hours, then q1h × 4 hours, then q4h** for next 24 hours. Watch for: - **Hypotension:** sign of bleeding; notify physician immediately if SBP drops >10–15 mmHg or HR increases >10 bpm. - **Tachycardia:** tachycardia + hypotension = significant blood loss. 3. **Hematuria:** expect some; document amount and trend. **Massive hematuria with clots, especially if ongoing, suggests significant bleeding → urgent physician notification and imaging (CT or ultrasound to assess for perinephric hematoma).** 4. **Flank pain:** expect mild soreness at biopsy site; use analgesics (acetaminophen, NSAIDs—avoid NSAIDs if bleeding concern). **Severe pain may indicate bleeding or hematoma → investigate immediately.** 5. **Urine output:** goal ≥30 mL/hr; encourage fluids (if no contraindication) to promote urine flow and early detection of bleeding (worsening hematuria = active bleeding). 6. **Dressing:** keep clean and dry; reinforce if leaking blood. Check for oozing from site. 7. **Avoid Valsalva:** no straining with bowel movements (increases intra-abdominal pressure, worsens bleeding). Stool softener often ordered. 8. **Ice pack:** to biopsy site may reduce pain/swelling (15–20 minutes, q2–3h). **Discharge Criteria (Usually 24–48 Hours Post-Biopsy):** - Stable vital signs with no signs of active bleeding. - Hematuria resolving (urine color normalizing from pink/red to clear). - Pain controlled. - Patient able to void without difficulty. - Patient tolerating diet. **Late Post-Procedure Care (After Hospital Discharge - 1–2 Weeks):** 1. **Activity restriction:** - Week 1: light activity only; avoid heavy lifting (>10 lbs), strenuous exercise, contact sports. - Week 2: gradually resume normal activity if no complications. 2. **Monitor urine:** contact physician if gross hematuria returns or if urine persistently discolored beyond 3–5 days. 3. **Flank/back pain:** contact if severe or worsening (may indicate ongoing bleeding or hematoma). 4. **Fever:** call immediately (risk of infection, though rare). 5. **Biopsy results:** usually available in 5–7 days; discuss findings with nephrologist; results guide treatment (immunosuppression, specific therapy depending on diagnosis). **Pathological Findings on Renal Biopsy** The pathologist examines the tissue under light microscopy (standard HE stain), immunofluorescence (antibody patterns—very important in GN), and electron microscopy (ultrastructure). Examples: - **IgA nephropathy:** IgA deposits on immunofluorescence; most common primary GN globally. - **Lupus nephritis:** immune complex deposits (IgG, IgA, IgM, C1q, C3); Class I–VI based on severity; affects prognosis and treatment intensity. - **Minimal change disease:** normal on light microscopy (despite massive proteinuria); foot process effacement on EM; usually responds well to corticosteroids. - **FSGS (focal segmental glomerulosclerosis):** sclerosis (scarring) of some glomeruli; poor prognosis; often requires immunosuppression.